GlassScriptPhysician profile
Charles Kaplan
NPI 1538261227
$16,607.35
in general payments reported to CMS, 2019-2025
44 companies · $2,696 in 2025
The $2,696 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,101 · 2020: $685 · 2021: $2,113 · 2022: $3,152 · 2023: $2,485 · 2024: $2,375 · 2025: $2,696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,696 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $820 · Consulting Fee: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,696.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $820.00 |
| Consulting Fee | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,378.40 | 2019-2025 | Advance Xp, Ams 700, Ams 800 Artificial Urinary Sphincter |
| Coloplast Corp | $2,799.58 | 2019-2025 | Titan, Speedicath |
| Medtronic, INC. | $1,220.91 | 2022-2025 | Interstim, Endo Clip III |
| Teleflex LLC | $702.48 | 2021-2025 | Barrigel, Urolift |
| Janssen Biotech, INC. | $529.86 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $503.55 | 2019-2023 | Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $429.91 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $338.68 | 2023-2025 | Orgovyx, Gemtesa |
| Endo Pharmaceuticals INC. | $314.55 | 2019-2024 | Xiaflex, Aveed |
| Srs Medical Systems, INC. | $305.02 | 2019-2021 | |
| Pfizer INC. | $241.72 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $241.30 | 2019-2025 | Lynparza, Keytruda, Keytruda Qlex |
| Myovant Sciences INC. | $234.16 | 2021-2022 | |
| Axonics, INC. | $227.17 | 2021-2024 | Bulkamid |
| Endo USA, INC. | $194.06 | 2024-2025 | Xiaflex, Aveed |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $179.68 | 2024-2025 | Xt Cdx |
| Dendreon Pharmaceuticals LLC | $157.56 | 2019-2025 | Provenge |
| Procept Biorobotics Corporation | $144.91 | 2019-2024 | Aquabeam System |
| Astrazeneca Pharmaceuticals LP | $144.48 | 2021-2025 | Lynparza |
| Urogen Pharma, INC. | $132.59 | 2021-2025 | Jelmyto |
| Laborie Medical Technologies Corp. | $128.98 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Tolmar, INC. | $123.25 | 2024-2025 | Eligard, Jatenzo |
| Myriad Genetic Laboratories, INC. | $120.26 | 2023-2025 | Prolaris |
| Antares Pharma, INC. | $117.21 | 2019-2024 | Xyosted |
| Abbvie INC. | $73.56 | 2019-2025 | |
| Medtronic USA, INC. | $56.52 | 2019-2020 | |
| Angiodynamics, INC. | $54.77 | 2022-2023 | Nanoknife |
| Verity Pharmaceuticals INC. | $53.94 | 2025 | Tlando, Trelstar |
| Neotract INC. | $52.52 | 2019-2020 | |
| Olympus America INC. | $49.21 | 2024-2025 | Itind System |
| Blue Earth Diagnostics | $46.26 | 2021 | |
| Amgen INC. | $45.09 | 2019-2020 | |
| Innovation Technologies INC | $38.92 | 2024-2025 | Irrisept |
| Ferring Pharmaceuticals INC. | $26.98 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $24.37 | 2025 | |
| Palette Life Sciences, INC. | $23.06 | 2022 | |
| Sun Pharmaceutical Industries INC. | $22.49 | 2024 | |
| Allergan, INC. | $20.78 | 2020 | |
| Progenics Pharmaceuticals, INC. | $20.50 | 2025 | |
| Travere Therapeutics, INC. | $20.21 | 2019-2021 | |
| Dornier Medtech America, INC | $20.13 | 2019 | |
| Azurity Pharmaceuticals, INC. | $16.86 | 2025 | Azmiro |
| Baxter Healthcare | $15.69 | 2019 | |
| Cycle Pharmaceuticals INC | $15.22 | 2025 | Venxxiva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Kaplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.